Search Results - CENTRAL NERVOUS SYSTEM AND PHARMACOTHERAPEUTICS

Refine Results
  1. 1

    Potential interactions of central nervous system drugs used in the elderly population by Fernanda Bueno Morrone, Guilherme Schroeter, Alessandra P. Petitembert, Fabiana T. Faggiani, Geraldo Atillio De Carli

    Get full text
    Article


  2. 2

    Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases by Walther Bild, Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela-Carmen Ababei, Aurelian Bogdan Stana, Gabriela Dumitrița Stanciu, Bogdan Savu, Veronica Bild

    Published in Biomolecules (2022-10-01)
    Get full text
    Article


  3. 3

    Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease by Kei Nakajima

    Published in International Journal of Hepatology (2012-01-01)
    Get full text
    Article


  4. 4

    Japanese encephalitis in north-east, India: Pharmacotherapeutic perspectives by Moksood Ahmed Laskar, Priyam Jyoti Das, Mrinmoy Basak, Juganta Kumar Kalita, Santa Mandal

    Published in The Microbe (2025-06-01)
    Get full text
    Article


  5. 5

    Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil by Robson Pierre Nascimento da Silva, Luana M. S. Marins, Lusiele Guaraldo, Paula Mendes Luz, Sandra W. Cardoso, Ronaldo I. Moreira, Vanessa da Gama Oliveira, Valdilea G. Veloso, Beatriz Grinsztejn, Rita Estrela, Thiago S. Torres

    Published in AIDS Research and Therapy (2023-08-01)
    “…Targeted interventions should be prioritized to prevent interactions and improve treatment, especially among individuals using central nervous system and cardiovascular medications, as well as certain groups such as cisgender women, older individuals and those with lower education. …”
    Get full text
    Article


  6. 6

    Assessment of pharmacotherapeutic safety of medical prescriptions for elderly residents in a long-term care facility by Fabiana Rossi Varallo, Ingrid Stephanie Stein Ambiel, Luana Orlandelli Nanci, José Carlos Fernandes Galduróz, Patricia de Carvalho Mastroianni

    “…Most of the PIM identified (53.4%) act on the central nervous system. Among the 13 different DI detected, 6 are considered PHDI. …”
    Get full text
    Article


  7. 7

    Prevalence of polypharmacy and pharmacotherapy complexity in elderly people living with HIV in Spain. POINT study by Mercedes Gimeno-Gracia, Javier Sánchez-Rubio-Ferrández, María de las Aguas Robustillo-Cortés, Ramón Morillo-Verdugo

    Published in Farmacia Hospitalaria (2020-07-01)
    “…The median number of comorbidities was 3.5 (2.0-5.0), 52.7% of them being cardiovascular; 50.0% related to the central nervous system; 17.6% hepatic; and 8.1% consisting in chronic pulmonary disease. …”
    Get full text
    Article


  8. 8

    Contribuição do uso de medicamentos para a admissão hospitalar by Patrícia de Carvalho Mastroianni, Fabiana Rossi Varallo, Marina Souza Barg, Ana Regina Noto, José Carlos Fernandez Galduróz

    Get full text
    Article


  9. 9

    Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems by Ruslan Safarov, Olga Fedotova, Anastasia Uvarova, Mariia Gordienko, Natalia Menshutina

    Published in Pharmaceuticals (2024-09-01)
    “…In recent decades, there has been an increased interest in the development of intranasal delivery systems for active pharmaceutical ingredients (APIs) not only for treating local nasal diseases but also for treating systemic diseases, central nervous system (CNS) disorders, and vaccine delivery. …”
    Get full text
    Article


  10. 10

    Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel by Munazza Ahmed, Ahlam M. Semreen, Alexander D. Giddey, Wafaa S. Ramadan, Raafat El-Awady, Nelson C. Soares, Waseem El-Huneidi, Yasser Bustanji, Mohammad A. Y. Alqudah, Karem H. Alzoubi, Mohammad H. Semreen

    Published in Annals of Medicine (2023-12-01)
    Get full text
    Article


  11. 11

    Insights into Exosome Transport through the Blood–Brain Barrier and the Potential Therapeutical Applications in Brain Diseases by Manal Abdelsalam, Munazza Ahmed, Zaynab Osaid, Rifat Hamoudi, Rania Harati

    Published in Pharmaceuticals (2023-04-01)
    Get full text
    Article


  12. 12

    Dopamine inhibits the expression of proinflammatory cytokines of microglial cells through the formation of dopamine quinone in the mouse striatum by Yasuhiro Yoshioka, Yuta Sugino, Akiko Yamamuro, Yuki Ishimaru, Sadaaki Maeda

    Published in Journal of Pharmacological Sciences (2022-01-01)
    Get full text
    Article


  13. 13

    Bridging regional neurovascular unit heterogeneity and cognitive function: a review by Amalia Tsintzou, Roseline Poirier, Rania Harati, Almira Kustubayeva, Clemence Disdier, Rifat Hamoudi, Aloïse Mabondzo

    Published in Fluids and Barriers of the CNS (2025-08-01)
    Get full text
    Article


  14. 14

    The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers by Florence Butlen-Ducuing, Marion Haberkamp, Georgios Aislaitner, Ewa Bałkowiec-Iskra, Taina Mattila, Marika Doucet, Marta Kollb-Sielecka, Pavel Balabanov, Ann-Kristin Leuchs, André Elferink

    Published in European Psychiatry (2024-01-01)
    Get full text
    Article


  15. 15

    Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations by Ruqaiyyah Siddiqui, Mutasem Rawas-Qalaji, Mohammed I. El-Gamal, Sreedevi Sajeev, Jayalakshmi Jagal, Seyed-Omar Zaraei, Rawan M. Sbenati, Hanan S. Anbar, Wolfgang Dohle, Barry V. L. Potter, Naveed Ahmed Khan

    Published in Antibiotics (2023-03-01)
    Get full text
    Article


  16. 16

    Anxiolytic-like effects of Pseudospondias microcarpa hydroethanolic leaf extract in zebrafish: Possible involvement of GABAergic and serotonergic pathways by Donatus Wewura Adongo, Charles Kwaku Benneh, Augustine Tandoh, Robert Peter Biney, Kennedy Kwami Edem Kukuia, Priscilla Kolibea Mante, Benjamin Kingsley Harley, David Oteng, Emmanuel Aduboffour Appiah, Ernest Cudjoe Anorbor, Eric Woode

    Published in Natural Products and Bioprospecting (2023-10-01)
    Get full text
    Article


  17. 17

    Hippocampal Ganglioside Composition is Altered by Metformin and Liraglutide Treatment in A High-Fat High-Sugar Diet Rat Model by Marin Kuharić, Vedrana Ivić, Milorad Zjalić, Anita Matić, Ines Drenjančević, Sandor G. Vari, Aleksandar Včev, Marija Heffer

    Published in Acta Clinica Croatica (2023-01-01)
    “…Insulin resistance has many deleterious effects on the central nervous system, including the initiation and potentiation of neurodegeneration. …”
    Get full text
    Article


  18. 18

    Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats by Coleman B. Calva, Habiba Fayyaz, Jim R. Fadel

    Published in Frontiers in Aging Neuroscience (2020-01-01)
    “…Fortunately, intranasal administration of native orexin peptides circumvents this issue and others concerning peptide transport into the central nervous system (CNS). To investigate the ability of intranasal orexin-A (OxA) administration to improve the anatomical, neurochemical, and behavioral substrates of age-related cognitive dysfunction, these studies utilized a rodent model of aging combined with acute intranasal administration of saline or OxA. …”
    Get full text
    Article


  19. 19

    Investigation of key interactions between the second extracellular loop of dopamine D2 receptor and several hydroxy-N-{[2-(4-phenyl-piperaziny-1-yl)ethyl]phenyl}-nicotinamides by Šukalović Vladimir, Šoškić Vukić, Ignjatović Đurđica, Andrić Deana, Penјišević Jelena, Kostić-Rajačić Slađana

    Published in Journal of the Serbian Chemical Society (2014-01-01)
    “…Dopaminergic receptor system has been in focus for the development of new pharmacotherapeutic agents, targeting number of central nervous system related disorders, like drug addiction, schizophrenia, depression, and Parkinson's disease, just to name a few. …”
    Get full text
    Article


  20. 20

    The involvement of K+ channels in depression and pharmacological effects of antidepressants on these channels by Xian-Tao Li

    Published in Translational Psychiatry (2024-10-01)
    “…It is well documented that K+ channels serve crucial roles in modulating the neuronal excitability and neurotransmitter release in the brain, and abnormality of these channels participated in the pathogenic process of diverse central nervous system (CNS) pathologies, such as seizure and Alzheimer’s disease (AD). …”
    Get full text
    Article


Search Tools: